Analysts: Amarin poised for huge gains if Vascepa trial comes back positive

Analysts from Jefferies predicted up to $2 billion in peak sales if Amarin's seven-year trial data is positive.

from Most popular articles from Medical Marketing and Media https://ift.tt/2OhHC3k